MedTrace Logo

Long-term Outcomes of Patients with Rheumatoid Arthritis in Remission

NCT06783322 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 259

Last updated 2025-03-10

No results posted yet for this study

Summary

The goal of this multi-center prospective observational study is to develop knowledge on how to best personalize treatment and follow-up strategies for patients with RA in remission, with the intention to prevent relapse of disease activity and progression of joint damage and at the same time avoid the use of unnecessary treatment and health resources.

The investigators will perform an extensive evaluation of all patients who participated in the ARCTIC REWIND study 10 and 15 years after they achieved sustained remission and received different treatment strategies.

Conditions

  • Rheumatoid Arthritis (RA)

Sponsors & Collaborators

  • South-Eastern Norway Regional Health Authority

    collaborator OTHER

  • The Research Council of Norway

    collaborator OTHER

  • Olav Thon Foundation

    collaborator UNKNOWN

  • Diakonhjemmet Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-30
Primary Completion
2034-01-31
Completion
2034-01-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06783322 on ClinicalTrials.gov